IMR OpenIR
Molecular and cellular mechanisms for zoledronic acid-loaded magnesium-strontium alloys to inhibit giant cell tumors of bone
Li, Mei1; Wang, Weidan2,3; Zhu, Ye4; Lu, Yao5; Wan, Peng6; Yang, Ke2; Zhang, Yu1; Mao, Chuanbin4,7
Corresponding AuthorWan, Peng(pwan@imr.ac.cn) ; Zhang, Yu(luck_2001@126.com) ; Mao, Chuanbin(cbmao@ou.edu)
2018-09-01
Source PublicationACTA BIOMATERIALIA
ISSN1742-7061
Volume77Pages:365-379
AbstractGiant Cell Tumors of Bone (GCTB) are benign but aggressive and metastatic tumors. Surgical removal cannot eradicate GCTB due to the subsequent recurrence and osteolysis. Here we developed Zoledronic acid (ZA)-loaded magnesium-strontium (Mg-Sr) alloys that can inhibit GCTB and studied the molecular and cellular mechanisms of such inhibition. We first formed a calcium phosphate (CaP) coating on the Mg-1.5 wt%Sr implants by coprecipitation and then loaded ZA on the CaP coating. We examined the response of GCTB cells to the ZA-loaded alloys. At the cellular level, the alloys not only induced apoptosis and oxidative stress of GCTB cells, and suppressed their resultant pre-osteoclast recruitment, but also inhibited their migration. At the molecular level, the alloys could significantly activate the mitochondrial pathway and inhibit the NF-KB pathway in the GCTB cells. These collectively enable the ZA-loaded alloys to suppress GCTB cell growth and osteolysis, and thus improve our understanding of the materials-induced tumor inhibition. Our study shows that ZA-loaded alloys could be a potential implant in repairing the bone defects after tumor removal in GCTB therapy. Statement of significance In clinics, giant cell tumors of bone (GCTB) are removed by surgery. However, the resultant defects in bone still contain aggressive and metastatic GCTB cells that can recruit osteoclasts to damage bone, leading to new GCTB tumor growth and bone damage after tumor surgery. Hence, it is of high demand in developing a material that can not only fill the bone defects as an implant but also inhibit GCTB in the defect area as a therapeutic agent. More importantly, the molecular and cellular mechanism by which such a material inhibits GCTB growth has never been explored. To solve these two problems, we prepared a new biomaterial, the Mg-Sr alloys that were first coated with calcium phosphate and then loaded with a tumor-inhibiting molecule (Zoledronic acid, ZA). Then, by using a variety of molecular and cellular biological assays, we studied how the ZA-loaded alloys induced the death of GCTB cells (derived from patients) and inhibited their growth at the molecular and cellular level. At the cellular level, our results showed that ZA-loaded Mg-Sr alloys not only induced apoptosis and oxidative stress of GCTB cells, and suppressed their induced pre-osteoclast recruitment, but also inhibited their migration. At the molecular level, our data showed that ZA released from the ZA-loaded Mg-Sr alloys could significantly activate the mitochondrial pathway and inhibit the NF-kappa B pathway in the GCTB cells. Both mechanisms collectively induced GCTB cell death and inhibited GCTB cell growth. This work showed how a biomaterial inhibit tumor growth at the molecular and cellular level, increasing our understanding in the fundamental principle of materials-induced cancer therapy. This work will be interesting to readers in the fields of metallic materials, inorganic materials, biomaterials and cancer therapy. (C) 2018 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
KeywordMagnesium-strontium alloys CaP coating Zoledronic acid Giant cell tumors of bone Mechanisms
Funding OrganizationNational Natural Science Foundation of China ; National Key Research and Development Program of China ; Natural Science Foundation of Guangdong Province, China ; National Institutes of Health
DOI10.1016/j.actbio.2018.07.028
Indexed BySCI
Language英语
Funding ProjectNational Natural Science Foundation of China[81501859] ; National Natural Science Foundation of China[31771038] ; National Natural Science Foundation of China[81601884] ; National Natural Science Foundation of China[51673168] ; National Key Research and Development Program of China[2017YFB0702604] ; National Key Research and Development Program of China[2016YFB0700800] ; National Key Research and Development Program of China[2016YFA0100900] ; Natural Science Foundation of Guangdong Province, China[2015A030313607] ; Natural Science Foundation of Guangdong Province, China[2015A030312004] ; National Institutes of Health[CA195607]
WOS Research AreaEngineering ; Materials Science
WOS SubjectEngineering, Biomedical ; Materials Science, Biomaterials
WOS IDWOS:000443668900032
PublisherELSEVIER SCI LTD
Citation statistics
Cited Times:15[WOS]   [WOS Record]     [Related Records in WOS]
Document Type期刊论文
Identifierhttp://ir.imr.ac.cn/handle/321006/129282
Collection中国科学院金属研究所
Corresponding AuthorWan, Peng; Zhang, Yu; Mao, Chuanbin
Affiliation1.Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Orthoped, Guangzhou 510080, Guangdong, Peoples R China
2.Chinese Acad Sci, Inst Met Res, Shenyang 110016, Liaoning, Peoples R China
3.Univ Chinese Acad Sci, Beijing 100049, Peoples R China
4.Univ Oklahoma, Inst Biomed Engn Sci & Technol, Stephenson Life Sci Res Ctr, Dept Chem & Biochem, Norman, OK 73019 USA
5.Guangzhou Mil Command, Guangzhou Gen Hosp, Guangdong Key Lab Orthopaed Technol & Implant Mat, Dept Orthoped, Guangzhou 510010, Guangdong, Peoples R China
6.Dongguan Univ Technol, Sch Mech Engn, Dongguan 523808, Peoples R China
7.Zhejiang Univ, Sch Mat Sci & Engn, Hangzhou 310027, Zhejiang, Peoples R China
Recommended Citation
GB/T 7714
Li, Mei,Wang, Weidan,Zhu, Ye,et al. Molecular and cellular mechanisms for zoledronic acid-loaded magnesium-strontium alloys to inhibit giant cell tumors of bone[J]. ACTA BIOMATERIALIA,2018,77:365-379.
APA Li, Mei.,Wang, Weidan.,Zhu, Ye.,Lu, Yao.,Wan, Peng.,...&Mao, Chuanbin.(2018).Molecular and cellular mechanisms for zoledronic acid-loaded magnesium-strontium alloys to inhibit giant cell tumors of bone.ACTA BIOMATERIALIA,77,365-379.
MLA Li, Mei,et al."Molecular and cellular mechanisms for zoledronic acid-loaded magnesium-strontium alloys to inhibit giant cell tumors of bone".ACTA BIOMATERIALIA 77(2018):365-379.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Li, Mei]'s Articles
[Wang, Weidan]'s Articles
[Zhu, Ye]'s Articles
Baidu academic
Similar articles in Baidu academic
[Li, Mei]'s Articles
[Wang, Weidan]'s Articles
[Zhu, Ye]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Li, Mei]'s Articles
[Wang, Weidan]'s Articles
[Zhu, Ye]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.